Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 20;14(1):R33.
doi: 10.1186/bcr3121.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Antonis C Antoniou  1 Karoline B KuchenbaeckerPenny SoucyJonathan BeesleyXiaoqing ChenLesley McGuffogAndrew LeeDaniel BarrowdaleSue HealeyOlga M SinilnikovaMaria A CaligoNiklas LomanKatja HarbstAnnika LindblomBrita ArverRichard RosenquistPer KarlssonKate NathansonSusan DomchekTim RebbeckAnna JakubowskaJan LubinskiKatarzyna JaworskaKatarzyna DurdaElżbieta Złowowcka-PerłowskaAna OsorioMercedes DuránRaquel AndrésJavier BenítezUte HamannFrans B HogervorstTheo A van OsSenno VerhoefHanne E J Meijers-HeijboerJuul WijnenEncarna B Gómez GarciaMarjolijn J LigtenbergMieke KriegeJ Margriet ColléeMargreet G E M AusemsJan C OosterwijkSusan PeockDebra FrostSteve D EllisRadka PlatteElena FinebergD Gareth EvansFiona LallooChris JacobsRos EelesJulian AdlardRosemarie DavidsonTrevor ColeJackie CookJoan PatersonFiona DouglasCarole BrewerShirley HodgsonPatrick J MorrisonLisa WalkerMark T RogersAlan DonaldsonHuw DorkinsAndrew K GodwinBetsy BoveDominique Stoppa-LyonnetClaude HoudayerBruno BuecherAntoine de PauwSylvie MazoyerAlain CalenderMélanie LéonéBrigitte Bressac-de PailleretsOlivier CaronHagay SobolMarc FrenayFabienne PrieurSandra U FerrerIsabelle MortemousqueSaundra BuysMary DalyAlexander MironMary U TerryJohn L HopperEsther M JohnMelissa SoutheyDavid GoldgarChristian F SingerAnneliese Fink-RetterMuy-Kheng TeaDaphne U KaulichThomas V HansenFinn C NielsenRosa B BarkardottirMia GaudetTomas KirchhoffVijai JosephAna Dutra-ClarkeKenneth OffitMarion PiedmonteJudy KirkDavid CohnJean HurteauJohn ByronJames FioricaAmanda E TolandMarco MontagnaCristina OlianiEvgeny ImyanitovClaudine IsaacsLaima TihomirovaIgnacio BlancoConxi LazaroAlex TeuléJ Del ValleSimon A GaytherKunle OdunsiJenny GrossBeth Y KarlanEdith OlahSoo-Hwang TeoPatricia A GanzMary S BeattieCecelia M DorflingElizabeth U van RensburgOrland DiezAva KwongRita K SchmutzlerBarbara WappenschmidtChristoph EngelAlfons MeindlNina DitschNorbert ArnoldSimone HeidemannDieter NiederacherSabine Preisler-AdamsDorothea GadzickiRaymonda Varon-MateevaHelmut DeisslerAndrea GehrigChristian SutterKarin KastBritta FiebigDieter SchäferTrinidad CaldesMiguel de la HoyaHeli NevanlinnaTaru A MuranenBernard LespéranceAmanda B SpurdleSusan L NeuhausenYuan C DingXianshu WangZachary FredericksenVernon S PankratzNoralane M LindorPaolo PeterlongoSiranoush ManoukianBernard PeisselDaniela ZaffaroniBernardo BonanniLoris BernardRiccardo DolcettiLaura PapiLaura OttiniPaolo RadiceMark H GreeneJennifer T LoudIrene L AndrulisHilmi OzcelikAnna U MulliganGord GlendonMads ThomassenAnne-Marie GerdesUffe B JensenAnne-Bine SkytteTorben A KruseGeorgia Chenevix-TrenchFergus J CouchJacques SimardDouglas F EastonCIMBA, SWE-BRCAHEBONEMBRACEGEMO Collaborators StudykConFab Investigators
Affiliations

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Antonis C Antoniou et al. Breast Cancer Res. .

Abstract

Introduction: Several common alleles have been shown to be associated with breast and/or ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Recent genome-wide association studies of breast cancer have identified eight additional breast cancer susceptibility loci: rs1011970 (9p21, CDKN2A/B), rs10995190 (ZNF365), rs704010 (ZMIZ1), rs2380205 (10p15), rs614367 (11q13), rs1292011 (12q24), rs10771399 (12p11 near PTHLH) and rs865686 (9q31.2).

Methods: To evaluate whether these single nucleotide polymorphisms (SNPs) are associated with breast cancer risk for BRCA1 and BRCA2 carriers, we genotyped these SNPs in 12,599 BRCA1 and 7,132 BRCA2 mutation carriers and analysed the associations with breast cancer risk within a retrospective likelihood framework.

Results: Only SNP rs10771399 near PTHLH was associated with breast cancer risk for BRCA1 mutation carriers (per-allele hazard ratio (HR) = 0.87, 95% CI: 0.81 to 0.94, P-trend = 3 × 10-4). The association was restricted to mutations proven or predicted to lead to absence of protein expression (HR = 0.82, 95% CI: 0.74 to 0.90, P-trend = 3.1 × 10-5, P-difference = 0.03). Four SNPs were associated with the risk of breast cancer for BRCA2 mutation carriers: rs10995190, P-trend = 0.015; rs1011970, P-trend = 0.048; rs865686, 2df-P = 0.007; rs1292011 2df-P = 0.03. rs10771399 (PTHLH) was predominantly associated with estrogen receptor (ER)-negative breast cancer for BRCA1 mutation carriers (HR = 0.81, 95% CI: 0.74 to 0.90, P-trend = 4 × 10-5) and there was marginal evidence of association with ER-negative breast cancer for BRCA2 mutation carriers (HR = 0.78, 95% CI: 0.62 to 1.00, P-trend = 0.049).

Conclusions: The present findings, in combination with previously identified modifiers of risk, will ultimately lead to more accurate risk prediction and an improved understanding of the disease etiology in BRCA1 and BRCA2 mutation carriers.

PubMed Disclaimer

References

    1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J. et al.Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;14:1117–1130. doi: 10.1086/375033. - DOI - PMC - PubMed
    1. Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL. Variation of breast cancer risk among BRCA1/2 carriers. JAMA. 2008;14:194–201. doi: 10.1001/jama.2007.55-a. - DOI - PMC - PubMed
    1. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, Kampjarvi K, Nevanlinna H, Simard J, Beesley J, Chen X, Neuhausen SL, Rebbeck TR, Wagner T, Lynch HT, Isaacs C, Weitzel J, Ganz PA, Daly MB, Tomlinson G, Olopade OI. et al.Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 2008;14:937–948. doi: 10.1016/j.ajhg.2008.02.008. - DOI - PMC - PubMed
    1. Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai PL, Rennert G, Lejbkowicz F, Andrulis IL. et al.Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet. 2009;14:4442–4456. doi: 10.1093/hmg/ddp372. - DOI - PMC - PubMed
    1. Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall'olio V, Peterlongo P, Szabo CI, Zikan M, Claes K. et al.Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res. 2010;14:9742–9754. doi: 10.1158/0008-5472.CAN-10-1907. - DOI - PMC - PubMed

Publication types